US equities
|
SPCX
$168.65
▲+6.10%
NVDA
$237.53
▲+1.53%
MU
$1,065.16
▼-0.91%
TSLA
$380.42
▲+2.65%
MSFT
$524.64
▲+1.37%
SNDK
$1,714.47
▼-0.32%
INTC
$116.83
▼-2.10%
META
$744.06
▲+2.19%
SPCX
$168.65
▲+6.10%
NVDA
$237.53
▲+1.53%
MU
$1,065.16
▼-0.91%
TSLA
$380.42
▲+2.65%
MSFT
$524.64
▲+1.37%
SNDK
$1,714.47
▼-0.32%
INTC
$116.83
▼-2.10%
META
$744.06
▲+2.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
MEDIFAST INC Common Stock
(NY:
MED
)
11.73
UNCHANGED
Delayed Quote
Updated: 1:24 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MEDIFAST INC Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment
September 30, 2026
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its...
Via
StockStory
Topics
Economy
3 Cash-Producing Stocks That Concern Us
August 31, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™
August 27, 2026
From
Medifast
Via
Business Wire
3 Unprofitable Stocks with Questionable Fundamentals
August 24, 2026
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Via
StockStory
Medifast (NYSE:MED) Q1 Loss Narrower Than Feared as Coach Productivity Improves
↗
May 04, 2026
Via
Chartmill
3 Reasons to Sell MED and 1 Stock to Buy Instead
August 21, 2026
Medifast trades at $11.62 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P 5...
Via
StockStory
Topics
Stocks
3 Small-Cap Stocks with Questionable Fundamentals
August 20, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
Topics
Artificial Intelligence
Medifast (MED) Q2 2026 Earnings Call Transcript
↗
August 10, 2026
Coach count plummeted 48.7%, yet management targets profitability by Q4 2026.
Via
The Motley Fool
Topics
Earnings
Medifast’s Q2 Earnings Call: Our Top 5 Analyst Questions
August 10, 2026
Medifast’s second quarter was marked by stabilization in key business metrics despite continued pressure from declining coach numbers and shifting industry t...
Via
StockStory
Topics
Earnings
1 Stock Under $50 to Consider Right Now and 2 We Turn Down
August 06, 2026
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Via
StockStory
Why Medifast (MED) Stock Is Trading Up Today
August 04, 2026
What Happened? Shares of wellness company Medifast (NYSE:MED) jumped 37.5% in the afternoon session after the company reported second-quarter results that su...
Via
StockStory
Topics
Artificial Intelligence
Economy
Stocks
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
August 04, 2026
Via
Chartmill
Top movers in Tuesday's session
↗
August 04, 2026
Via
Chartmill
Medifast Q2 Earnings Call Highlights
↗
August 03, 2026
Medifast (NYSE:MED) reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1...
Via
MarketBeat
Topics
Earnings
Medifast (NYSE:MED) Beats Expectations in Strong Q2 CY2026, Stock Jumps 12.8%
August 03, 2026
Wellness company Medifast (NYSE:MED) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 27.6% year on year to $76.38 mil...
Via
StockStory
Topics
Artificial Intelligence
11 Consumer Staples Stocks Moving In Monday's After-Market Session
↗
August 03, 2026
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came...
Via
Benzinga
Medifast Announces Second Quarter 2026 Financial Results
August 03, 2026
From
Medifast
Via
Business Wire
Earnings To Watch: Medifast (MED) Reports Q2 Results Tomorrow
August 01, 2026
Wellness company Medifast (NYSE:MED) will be reporting results this Monday after market hours. Here’s what you need to know. Medifast beat analysts’ revenue ...
Via
StockStory
3 Out-of-Favor Stocks with Questionable Fundamentals
July 27, 2026
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether...
Via
StockStory
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
July 20, 2026
From
Medifast
Via
Business Wire
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
July 17, 2026
From
Medifast
Via
Business Wire
3 Unpopular Stocks That Concern Us
July 16, 2026
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Via
StockStory
Topics
Artificial Intelligence
A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack
July 13, 2026
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Via
StockStory
Topics
Economy
1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds
July 10, 2026
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...
Via
StockStory
3 Reasons MED is Risky and 1 Stock to Buy Instead
July 07, 2026
Since January 2026, Medifast has been in a holding pattern, posting a small return of 3.3% while floating around $11.05. Is now the time to buy Medifast, or ...
Via
StockStory
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
May 26, 2026
From
Medifast
Via
Business Wire
Medifast (MED) Q1 2026 Earnings Transcript
↗
May 04, 2026
Medifast (MED) Q1 2026 Earnings Transcript
Via
The Motley Fool
Medifast (NYSE:MED) Delivers Impressive Q1 CY2026
May 04, 2026
Wellness company Medifast (NYSE:MED) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 34.3% year on year to $76.04 m...
Via
StockStory
Medifast Announces First Quarter 2026 Financial Results
May 04, 2026
From
Medifast
Via
Business Wire
Medifast (MED) Q1 Earnings: What To Expect
May 02, 2026
Wellness company Medifast (NYSE:MED) will be reporting earnings this Monday afternoon. Here’s what to expect. Medifast beat analysts’ revenue expectations la...
Via
StockStory
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
